117011-70-8

Basic information

• Product Name: 2-(4-Aminophenoxy)-2-methylpropionic acid
• Synonyms: 2-(4-AMINOPHENOXY)-2-METHYLPROPANOIC ACID;2-(4-AMINO-PHENOXY)-2-METHYL-PROPIONIC ACID;Propanoic acid, 2-(4-aMinophenoxy)-2-Methyl-;2-(4-Aminophenoxy)-2-methyl-propanoic acid HCl
• CAS NO: 117011-70-8
• Molecular Formula: C₁₀H₁₃NO₃
• Molecular Weight: 195.22
• Product Categories: pharmacetical
• Mol File: 117011-70-8.mol
• Article Data: 13

Chemical Properties

• Melting Point: 214-216 °C (decomp)
• Boiling Point: 364.6 °C at 760 mmHg
• Flash Point: 174.3 °C
• Appearance: /
• Density: 1.22 g/cm³
• Vapor Pressure: 5.9E-06mmHg at 25°C
• Refractive Index: 1.571
• Storage Temp.: 2-8°C(protect from light)
• PKA: 3.08±0.10(Predicted)
• CAS DataBase Reference: 2-(4-Aminophenoxy)-2-methylpropionic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Aminophenoxy)-2-methylpropionic acid(117011-70-8)
• EPA Substance Registry System: 2-(4-Aminophenoxy)-2-methylpropionic acid(117011-70-8)

Safety Data

• Statements: 43
• Safety Statements: 36/37
• Hazardous Substances Data: 117011-70-8(Hazardous Substances Data)

Usage

General Description

The chemical 2-(4-Aminophenoxy)-2-methylpropionic acid is a compound with the molecular formula C11H15NO3. It is a derivative of propionic acid with a 4-aminophenol group attached to the second carbon atom. This chemical is commonly used in the synthesis of pharmaceuticals and organic compounds due to its unique structure and properties. It is also utilized in the development of new drugs and as a building block for the creation of various organic compounds. Additionally, it has potential applications in the fields of medicine, biotechnology, and materials science due to its versatile nature and reactivity.

InChI:InChI=1/C10H13NO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,11H2,1-2H3,(H,12,13)

Upstream product

• 17413-84-2 2-(4-acetaminophenoxy)-2-methylpropionic acid 
• 100-02-7 4-nitro-phenol 
• 2052-01-9 2-bromo-2-methylpropionic acid 
• 123-30-8 4-amino-phenol 
• 103-90-2 4-acetaminophenol 
• 79925-16-9 2-(4-cyanophenoxy)-2-methylpropionic acid 
• 767-00-0 4-cyanophenol 
• 7159-95-7 (4-hydroxyphenyl)carbamic acid ethyl ester 
• 121809-55-0 2-<4-<(ethoxycarbonyl)amino>phenoxy>-2-methylpropionic acid 
• 121809-54-9 2-(4-carbamoylphenoxy)-2-methylpropionic acid 
• 17431-97-9 2-(4-nitrophenoxy)-2-methylpropanoic acid 

Downstream Products

• 121809-78-7 2-{4-[3-(2,4-Dichloro-phenyl)-ureido]-phenoxy}-2-methyl-propionic acid 
• 121809-90-3 4-(4-ethylcarbamatophenylureido)phenoxyisobutyric acid 
• 121809-59-4 2-<4-<<<(4-chlorophenyl)amino>imino>methyl>phenoxy>-2-methylpropionic acid 
• 121809-65-2 4-(4-methylphenylureido)phenoxyisobutyric acid 
• 121809-80-1 2-<4<<<(3,5-dichlorophenyl)amino>carbonyl>amino>phenoxy>-2-methylpropionic acid 
• 121809-94-7 4-(4-carboxyphenylureido)phenoxyisobutyric acid 
• 1453211-13-6 2-[4-({5-[(2,6-difluoro-3,5-dimethoxybenzyl)oxy]pyrimidin-2-yl}amino)phenoxy]-2-methylpropionic acid 
• 1365890-42-1 C₂₆H₂₂N₂O₄ 
• 1365890-36-3 C₁₇H₁₅Cl₂NO₄ 
• 1365890-33-0 C₁₅H₁₉NO₆ 

Relevant articles and documents

Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents

A novel series of substituted quinazoline derivatives were designed, synthesized and evaluated for their hypolipidemic activity in cholesterol induced hyperlipidemic rats. In vivo screening concluded that compounds A-4, C-5 and C-6 have shown potent antihyperlipidemic activity by decreasing the plasma level of triglycerides (TG), very low density lipoprotein (VLDL), low density lipoprotein (LDL), followed by increase in level of high density lipoprotein (HDL).

Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood

A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood during storage and can restore the oxygen affinity of outdated blood.

Medical uses of allosteric hemoglobin modifier compounds in patient care

A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The effect has particular application in a wide variety of treatments including hypoxia, hypothermia, ischemia, stroke, ARDS, COPD, surgical blood loss, acute nonvolemic hemodilutions, wounds, diabetic ulcers, chronic leg ulcers, pressure sores, tissue transplants, and sepsis. The compounds are capable of acting on hemoglobin in whole blood.